REPL vs REGN: Which Stock is Better?
Side-by-side comparison of Replimune Group Inc and Regeneron Pharmaceuticals Inc in 2026
REPL
Replimune Group Inc
—
REGN
Regeneron Pharmaceuticals Inc
$623.43
Key Metrics Comparison
| Metric | REPL | REGN | Winner |
|---|---|---|---|
| Market Cap | $825.73M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze REPL
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REPL or REGN a better investment?
Comparing REPL and REGN: Replimune Group Inc has a market cap of $825.73M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REPL and REGN?
REPL (Replimune Group Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REPL or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: REPL or REGN?
Both REPL and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: REPL or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: REPL or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $825.73M for REPL.
Should I buy REPL or REGN in 2026?
Both REPL and REGN have investment merit. REPL trades at $N/A while REGN trades at $623.43. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REPL and REGN stock?
Key differences: Market Cap ($825.73M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy REPL or REGN in 2026?
The choice between REPL and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between REPL and REGN?
REPL (Replimune Group Inc) has a market cap of $825.73M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.